Filing metadata

Accession number
0001209191-22-026106
Form type
Form 3
Filer
Karyopharm Therapeutics Inc.
CIK
CIK 1503802
Filed
Apr 29, 2022
Reporting period
Apr 19, 2022
Description
Initial ownership

Explore SEC Filings Hub